HNSCC, whereas the combination of durvalumab and cetuximab showed limited success. Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib ...
The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...
Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...
The US oncology biosimilar market has rapidly evolved since its launch in 2017, driven by steep price discounts, payer ...
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...
Bristol Myers Squibb (NYSE:BMY) said that ongoing initiatives to cut costs will lead to the realization of $1.5B in annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback